Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report
Abstract Tardive dyskinesia (TD) is a common side effect of antipsychotics, and it remains a persistent and challenging problem. The blonanserin transdermal patch, developed in Japan and launched in September 2019, is the first antipsychotic transdermal treatment. Here, we describe a patient with sc...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2021-09-01
|
| coleção: | Neuropsychopharmacology Reports |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/npr2.12200 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|